MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Uncover how genetic testing aids in diagnosing SETD5 haploinsufficiency syndrome, guiding personalized treatment, family planning, and early interventions.
Explore how genetic testing aids in diagnosing intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome, enabling early intervention and personalized…
Explore the impact of genetic testing in diagnosing intellectual disability-hypotonia-spasticity-sleep disorder syndrome, focusing on the NSUN2 gene variant.
Explore how genetic testing aids in diagnosing and managing Joubert Syndrome 21, from identifying mutations to guiding treatment and enabling informed family planning.
Explore how genetic testing, focusing on SUFU gene variants, aids in diagnosing and managing Joubert Syndrome 22, offering insights into early intervention and family planning.
Explore how genetic testing aids in diagnosing Juvenile Onset Parkinson Disease 19A. Uncover insights on early detection, personalized treatments, and family risk assessment.
Explore how genetic testing accurately diagnoses L-ferritin deficiency, distinguishing it from other iron disorders, and enables personalized treatment plans.
Explore how genetic testing impacts acute lymphoblastic leukemia (ALL) risk assessment, personalized treatment, and family planning with cutting-edge insights.